Metzler is an assistant professor of urology at Oregon Health & Science University School of Medicine in Portland, Oregon.
Ian Metzler, MD, on the role for telemedicine, digital health tools in stone disease
“We have to understand as providers that we're not going to be the one and only conduit for this information anymore, which is a good thing, to be honest," says Ian Metzler, MD, MTM.
Ian Metzler, MD, highlights recent advances in kidney stone technology
Ian Metzler, MD, discusses developments in imaging and treating stones.
Ian Metzler, MD, on the increasing prevalence of kidney stones in women
“I think it's primarily due to dietary changes that are more and more prevalent regardless of sex,” says Ian Metzler, MD, MTM.
FDA awards Regenerative Medicine Advanced Therapy Designation to CAN-2409 for prostate cancer
Intraprostatic drug elution therapy shows promise for BPH-related LUTS
Subcutaneous nivolumab approved in EU, Canada for solid tumors
Phase 3 trial of tebipenem HBr for cUTI stopped early for efficacy